Levocetrizine

# Levocetrizine ## Overview - **Classification**: Second-generation H1-receptor antagonist (non-sedating antihistamine). - **Mechanism**: Selectively inhibits peripheral H1 receptors, blocking the effects of histamine and reducing allergic symptoms. ## Primary Indications 1. **Seasonal Allergic Rhinitis** - Relief of sneezing, rhinorrhea, pruritus, and watery eyes. 2. **Perennial Allergic Rhinitis** - Management of chronic nasal allergy symptoms. 3. **Chronic Idiopathic Urticaria** - Treatment of hives and itching of unknown cause. ## Adult Dosing ### Standard Dosing **Allergic Rhinitis (Seasonal/Perennial) & Chronic Idiopathic Urticaria** - **Dose**: **5 mg** - **Frequency**: Once daily, usually in the evening - **Route**: Oral (tablet or oral solution) - **Maximum Dose**: **5 mg/day** ### Dose Adjustments - **Renal Impairment**: - CrCl 50-79 mL/min: **5 mg** every other day. - CrCl 30-49 mL/min: **5 mg** twice weekly. - CrCl 10-29 mL/min: **5 mg** once weekly. - ESRD (CrCl < 10 mL/min) or Hemodialysis: **Contraindicated**. - **Hepatic Impairment**: No dose adjustment needed for hepatic impairment alone. - **Elderly Patients**: Consider starting at lower end of dosing range; adjust based on renal function. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: Not recommended. - **Special Notes**: Safety and efficacy not established in infants <6 months of age. ### Infants (6-12 months) - **Indication**: Allergic Rhinitis, Chronic Idiopathic Urticaria. - **Dose**: **1.25 mg** - **Frequency**: Once daily. - **Route**: Oral solution. - **Maximum**: **1.25 mg/day**. - **Special Notes**: Approved for infants **6 months to <2 years**. ### Children (1-12 years) - **Indication**: Allergic Rhinitis, Chronic Idiopathic Urticaria. - **Ages 2 to 5 years**: - **Dose**: **1.25 mg** - **Frequency**: Once daily. - **Route**: Oral solution. - **Maximum**: **1.25 mg/day**. - **Ages 6 to 11 years**: - **Dose**: **2.5 mg** - **Frequency**: Once daily. - **Route**: Oral solution or tablet (if able to swallow). - **Maximum**: **2.5 mg/day**. ### Adolescents (13-18 years) - **Indication**: Allergic Rhinitis, Chronic Idiopathic Urticaria. - **Dose**: **5 mg** - **Frequency**: Once daily. - **Route**: Oral (tablet or solution). - **Maximum**: **5 mg/day**. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to levocetirizine or cetirizine. - **Absolute**: End-stage renal disease (CrCl < 10 mL/min) or hemodialysis. - **Absolute**: Infants 0-6 months of age. - **Absolute**: Patients with a known intolerance to any of the excipients. ### Common Adverse Effects - **Very Common (>10%)**: Somnolence/drowsiness, fatigue, nasopharyngitis (in children). - **Common (1-10%)**: Dry mouth, headache, pharyngitis, cough, dizziness, fever (in children). - **Serious but Rare**: Angioedema, anaphylaxis, seizures, severe hepatic dysfunction, urinary retention. ### Key Drug Interactions - **CNS Depressants (alcohol, sedatives)**: Increased CNS depression (drowsiness, impaired performance). Avoid concurrent use. - **Ritonavir**: May increase levocetirizine exposure. Monitor for increased adverse effects. - **Theophylline**: May decrease levocetirizine clearance. Clinical significance generally minor, monitor if co-prescribed. ## Monitoring & Follow-up - **Before Treatment**: Assess renal function (CrCl) to guide dosing. - **During Treatment**: Monitor for symptom improvement and adverse effects. - **Clinical Signs**: Watch for excessive drowsiness, dizziness, or signs of urinary retention. ## Clinical Pearls - 💡 **Timing**: Taking levocetirizine in the evening can help mitigate dose-dependent drowsiness. - 💡 **Formulation**: Oral solution is available for young children and those unable to swallow tablets. - 💡 **Sedation**: While considered "non-sedating," it can still cause drowsiness in some patients, especially at higher doses or with CNS depressants. - 💡 **Renal Function**: Always assess and adjust dose based on renal function to prevent accumulation and increased adverse effects. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.